Bard® InLay® Ureteral Stent with NiCore™ Guidewire 776624Recalls & reported problems
C. R. Bard, Inc. · INLAY URETERAL STENT W/NITINOL GUIDEWIRE · Class 2 · Implant
All models of Bard InLay Ureteral Stent with NiCore Guidewire (7)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 10801741014267), received between Oct 26, 2021 and Nov 1, 2021 — classified as 4 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Biocompatibility” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Biocompatibility4
- Patient Device Interaction Problem3
- Calcified2
- Device Dislodged or Dislocated1
- Migration1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available2
- Calcium Deposits/Calcification2
- Discomfort1
- Pain1
- Swelling/ Edema1
- Unspecified Infection1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 1, 2021Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PATIENT EXPERIENCED EDEMA, STONE FORMATION, URETERAL REFLUX, STENT DISLODGEMENT, MIGRATION, STENT ENCRUSTATION, INFECTION, PAIN AND DISCOMFORT WHILE USING THE BARD URETERAL STENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12727930 ↗InjuryOct 27, 2021Biocompatibility; Patient Device Interaction Problem; Biocompatibility; Patient Device Interaction Problem
IT WAS REPORTED THAT THE PATIENT EXPERIENCED EDEMA, STONE FORMATION, URETERAL REFLUX, STENT DISLODGEMENT, MIGRATION, STENT ENCRUSTATION, INFECTION, PAIN AND DISCOMFORT WHILE USING THE BARD URETERAL STENT. IT WAS UNKNOWN WHAT MEDICAL INTERVENTION WAS PROVIDED.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 12706235 ↗InjuryOct 27, 2021Calcified; Biocompatibility; Calcified; Biocompatibility
IT WAS REPORTED THAT THE PATIENT EXPERIENCED EDEMA, STONE FORMATION, URETERAL REFLUX, STENT DISLODGEMENT, MIGRATION, STENT ENCRUSTATION, INFECTION, PAIN AND DISCOMFORT WHILE USING THE BARD URETERAL STENT. MEDICAL INTERVENTION WAS UNKNOWN.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Calcium Deposits/Calcification
MAUDE report 12704906 ↗InjuryOct 26, 2021Biocompatibility; Patient Device Interaction Problem; Biocompatibility; Patient Device Interaction Problem
IT WAS REPORTED THAT THE PATIENT EXPERIENCED EDEMA, STONE FORMATION, URETERAL REFLUX, STENT DISLODGEMENT, MIGRATION, STENT ENCRUSTATION, INFECTION, PAIN AND DISCOMFORT WHILE USING THE BARD URETERAL STENT. IT WAS UNKNOWN WHAT MEDICAL INTERVENTION WAS PROVIDED FOR INFECTION.
Patient problems: Unspecified Infection
MAUDE report 12698798 ↗MalfunctionOct 26, 2021Calcified; Calcified
IT WAS REPORTED THAT THE PATIENT EXPERIENCED EDEMA, STONE FORMATION, URETERAL REFLUX, STENT DISLODGEMENT, MIGRATION, STENT ENCRUSTATION, INFECTION, PAIN AND DISCOMFORT WHILE USING THE BARD URETERAL STENT. MEDICAL INTERVENTION WAS UNKNOWN.
Patient problems: Calcium Deposits/Calcification; No Clinical Signs, Symptoms or Conditions
MAUDE report 12698748 ↗InjuryOct 26, 2021Biocompatibility; Patient Device Interaction Problem; Biocompatibility; Patient Device Interaction Problem
IT WAS REPORTED THAT THE PATIENT EXPERIENCED EDEMA, STONE FORMATION, URETERAL REFLUX, STENT DISLODGEMENT, MIGRATION, STENT ENCRUSTATION, INFECTION, PAIN AND DISCOMFORT WHILE USING THE BARD URETERAL STENT. MEDICAL INTERVENTION WAS UNKNOWN
Patient problems: Discomfort; Pain; Swelling/ Edema
MAUDE report 12698601 ↗MalfunctionOct 26, 2021Migration; Migration
IT WAS REPORTED THAT THE PATIENT EXPERIENCED EDEMA, STONE FORMATION, URETERAL REFLUX, STENT DISLODGEMENT, MIGRATION, STENT ENCRUSTATION, INFECTION, PAIN AND DISCOMFORT WHILE USING THE BARD URETERAL STENT. NO MEDICAL INTERVENTION WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12698355 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page